Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kura Oncology

6.56
+0.04000.61%
Volume:967.18K
Turnover:6.31M
Market Cap:529.90M
PE:-3.25
High:6.59
Open:6.46
Low:6.43
Close:6.52
Loading ...

Kura Oncology Is Maintained at Buy by UBS

Dow Jones
·
07 Mar

UBS Adjusts Price Target on Kura Oncology to $14 From $27, Keeps Buy Rating

MT Newswires Live
·
06 Mar

Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)

TIPRANKS
·
03 Mar

Kura Oncology’s Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns

TIPRANKS
·
02 Mar

Kura Oncology (NASDAQ:KURA) shareholders have endured a 64% loss from investing in the stock a year ago

Simply Wall St.
·
28 Feb

Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Kura Oncology (KURA) and Silence Therapeutics (SLN)

TIPRANKS
·
28 Feb

Q4 2024 Kura Oncology Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Bullish Outlook for Kura Oncology: Buy Rating Affirmed Amid Optimism for Ziftomenib Approval and Competitive Advantage

TIPRANKS
·
27 Feb

Kura Oncology’s Promising Pipeline and Strategic Focus Justify Buy Rating

TIPRANKS
·
27 Feb

Kura Oncology Inc (KURA) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Growth

GuruFocus.com
·
27 Feb

Kura Oncology’s Promising Path to FDA Approval: Analyst Recommends ‘Buy’ Following Positive Phase II Results and Strategic Advancements

TIPRANKS
·
27 Feb

Kura Oncology’s Strategic Advancements and Financial Health Drive Buy Rating

TIPRANKS
·
27 Feb

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb

Kura Oncology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Stock Track | Kura Oncology Soars 6.69% After-Hours on Positive Q4 Results and Clinical Trial Updates

Stock Track
·
27 Feb

Kura Oncology: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Kura Oncology Q4 GAAP EPS $(0.22) Beats $(0.65) Estimate, Sales $53.88M Beat $8.50M Estimate

Benzinga
·
27 Feb

BRIEF-Kura Oncology Q4 Operating Expenses USD 76.338 Million

Reuters
·
27 Feb

Analysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Kura Oncology (KURA)

TIPRANKS
·
07 Feb

BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
07 Feb